‘Particles for Humanity’ has selected the final product and manufacturing process for its stable form of vitamin A

Cambridge, MA (June 30, 2022) – Particles for Humanity has selected the final product and manufacturing process for its stable form of vitamin A, PFH-VAP, to be used. This achievement is a major milestone in the grant, triggering a payment of $1 million.

Find out more: download the press release

Share this article:

You may also read...